港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

抗疫概念

875.916

-12.161-1.37%

漲家數：3

跌家數：13

平家數：1

市盈率：- -

高：893.115

開：887.975

低：873.648

收：888.076

成交量：2.59億

成交額：17.47億

市值：5,923.57億

流通市值：4,901.67億

資料載入中...

總覽新聞資訊

復星醫藥(02196)9月14日斥資2470.51萬港元回購145.5萬股

國家醫保局公布價格招採信用評價「特別嚴重失信」和「嚴重失信」名單

石藥集團(01093.HK)：SYS 6010聯合恩朗蘇拜單抗用於治療未經系統性治療的驅動基因陰性晚期NSCLC的I / II期臨床研究數據於2026年世界肺癌大會(WCLC)上以口頭報告形式公布

市場縮量調整，三大指數震盪回調，醫藥銀行集體護盤| 華寶基金3A日報（2026.9.14）

復星醫藥(02196)股價上升5.021%，現價港幣$17.15

阿斯达克财经

新股前瞻|攻克抗生素耐藥性難題，普萊醫藥闖關港股能否獲市場下注？

高盛：上調中國生物製藥(01177.HK)目標價至9.07港元重申「買入」評級

君實生物(01877)股價上升5.06%，現價港幣$17.44

阿斯达克财经

港股異動 | 君實生物(01877)升逾3% 兩款雙特異性抗體新藥均計劃在年內啓動關鍵III期臨床研究

《大行》大華繼顯：手機供應鏈分化看好「果鏈股」及AI硬件商維持行業「增持」評級

阿斯达克财经

《大行》野村：中生製藥(01177.HK)向大股東增購正大天晴5%股權市場認可交易戰略價值惟對估值存疑

阿斯达克财经

《股市簡訊》復星醫藥H股升2.5%，地舒單抗生物類似藥HLX14的註冊申請獲受理

醫藥板塊表現強勢凱萊英（06821）升逾5% 機構制AI製藥商業化風口初步顯現

港股異動 | 中國生物製藥(01177.HK)升逾3% 擬44.8億元向謝承潤收購正大天晴5%股權

港股公告掘金 | 中國生物製藥擬44.8億元向謝承潤收購正大天晴5%股權完成後間接持股增至65%

【灣區早參】澳門第二季本地產品出口總值按季上升6.8%；廣州金融業總資產首次突破14萬億元

國家醫保局修訂印發2026版醫保服務協議範本

智通港股早知道 | 沙特輸油管道中斷全球石油供應恐損失4%

20%漲停效應顯現？公募調研醫藥挖出這三家雙創標的

证券市场周刊

河北一醫院工作人員先後收受商業賄賂46次，單次最大涉案金額1658萬元，持續時間最長達11年，累計涉案金額1.84億元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/BK1515/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":875.9157,"timestamp":1789459707407,"preClose":888.07635,"halted":0,"volume":258517563,"delay":0,"changeRate":-0.013693,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":-12.160645,"latestTime":"09-15 16:00:00","open":887.9753,"high":893.115,"low":873.64844,"amount":1747446787,"amplitude":0.02192,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789522200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789435800000,1789444800000],[1789448400000,1789459200000]],"pbRate":1.333444,"peRate":17.280209,"turnoverRate":0.003315,"increases":2,"decrements":13,"flats":2,"marketCap":592357498176,"floatMarketCap":490167420608},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":893.115,"amplitude":0.02192,"preClose":888.07635,"low":873.64844,"pbRate":"1.333444","latestPrice":875.9157,"volume":258517563,"delay":0,"open":887.9753,"prevYearClose":1190.107,"prevWeekClose":878.789,"prevMonthClose":925.265,"prevQuarterClose":802.777,"fiveDayClose":942.498,"twentyDayClose":909.79,"sixtyDayClose":823.11,"secType":"PLATE","market":"HK","turnoverRate":0.003315,"peRate":17.280209,"marketCap":592357498176,"floatMarketCap":490167420608,"timestamp":1789459707407,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":3,"down":13,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667575016","title":"復星醫藥(02196)9月14日斥資2470.51萬港元回購145.5萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667575016","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667575016?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:12","pubTimestamp":1789380740,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(02196)发布公告，于2026年9月14日，该公司斥资2470.51万港元回购145.5万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0060","02196","BK0183","BK0187","BK1593","BK0239","BK0012","BK1191","BK0196","600196","BK0096","BK0175","BK1515","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667983650","title":"國家醫保局公布價格招採信用評價「特別嚴重失信」和「嚴重失信」名單","url":"https://stock-news.laohu8.com/highlight/detail?id=2667983650","media":"央视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667983650?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:00","pubTimestamp":1789380000,"startTime":"0","endTime":"0","summary":"受国家医疗保障局委托，国家医疗保障局医药价格和招标采购指导中心汇总了截至2026年7月1日各省份评级为“特别严重失信”和“严重失信”的医药企业情况，现公告如下。注3：价格招采信用评级主要依据行贿金额、不正当价格行为、扰乱集中采购秩序等严重程度进行确定。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-14/doc-iniruxuu7272468.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","BK1161","09939","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667269654","title":"石藥集團(01093.HK)：SYS 6010聯合恩朗蘇拜單抗用於治療未經系統性治療的驅動基因陰性晚期NSCLC的I / II期臨床研究數據於2026年世界肺癌大會(WCLC)上以口頭報告形式公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2667269654","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667269654?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:34","pubTimestamp":1789378468,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BZ08YS42.EUR","LU1993786604.SGD","LU1226288253.USD","01093","IE00BZ08YT58.USD","LU1152091168.USD","LU0314109678.HKD","SG9999004220.SGD","LU0140636845.USD","IE00B5MMRT66.SGD","LU1226287875.USD","KURE","BK1515","HK0000165453.HKD","BK1191","IE0008369823.USD","LU0326950275.SGD","LU1008478684.HKD","IE00BZ08YR35.GBP","LU1226287792.SGD","LU1807302812.USD","LU1328277881.USD","LU1960683339.HKD","LU1813983027.USD","LU0072913022.USD","IE0008368742.USD","LU1951186391.HKD","LU0501845795.SGD","LU1226287529.USD","BK1521","LU1152091754.HKD","LU1226288170.HKD","IE00B031HY20.USD","LU0067412154.USD","LU0880133367.SGD","LU0315179316.USD","LU2039709279.SGD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667654038","title":"市場縮量調整，三大指數震盪回調，醫藥銀行集體護盤| 華寶基金3A日報（2026.9.14）","url":"https://stock-news.laohu8.com/highlight/detail?id=2667654038","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667654038?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 17:30","pubTimestamp":1789378200,"startTime":"0","endTime":"0","summary":"MACD金叉信号形成，这些股涨势不错！","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-14/doc-inirutpa4636245.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","BK1574","BK1161","161121","09939","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667353659","title":"復星醫藥(02196)股價上升5.021%，現價港幣$17.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2667353659","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667353659?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:59","pubTimestamp":1789372740,"startTime":"0","endTime":"0","summary":"[上升股]复星医药(02196) 股价在下午03:58比前收市价上升5.021%，现股价为港币$17.15。至目前为止，今日最高价为$17.15，而最低价为$16.12。总成交量为571.7万股，总成交金额为港币$9.677千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609141758/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609141758/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["600196","BK0183","BK0239","BK1593","BK0187","BK1515","02196","BK0012","BK0060","BK0028","BK0175","BK0196","BK1191","BK0188","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667765505","title":"新股前瞻|攻克抗生素耐藥性難題，普萊醫藥闖關港股能否獲市場下注？","url":"https://stock-news.laohu8.com/highlight/detail?id=2667765505","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667765505?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:36","pubTimestamp":1789371362,"startTime":"0","endTime":"0","summary":"近日，普莱医药向港交所主板递交上市申请，中信证券担任独家保荐人，这是公司继2月13日首次提交上市申请后的第二次递表。目前的治疗药物以唑类抗真菌药为主，但耐药性问题同样存在。目前该产品正在中国进行一项II期临床试验，且已获FDA批准在美国进行一项II期临床试验。整体来看，在全球抗生素耐药性问题日益严峻的背景下，抗菌肽作为新型抗感染药物具备广阔的市场前景。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495584.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","BK1515","KCAI","BK1161","BK1574","BK4588","159938","BK4585","09939"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2667655361","title":"高盛：上調中國生物製藥(01177.HK)目標價至9.07港元 重申「買入」評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2667655361","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667655361?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 14:48","pubTimestamp":1789368529,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BZ08YT58.USD","BK1521","BK1191","IE00BZ08YR35.GBP","01177","BK1515","HK0000165453.HKD","IE00BZ08YS42.EUR","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667653905","title":"君實生物(01877)股價上升5.06%，現價港幣$17.44","url":"https://stock-news.laohu8.com/highlight/detail?id=2667653905","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667653905?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 14:40","pubTimestamp":1789368000,"startTime":"0","endTime":"0","summary":"[上升股]君实生物(01877) 股价在下午02:39比前收市价上升5.06%，现股价为港币$17.44。至目前为止，今日最高价为$17.44，而最低价为$16.4。总成交量为145.8万股，总成交金额为港币$2.475千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609141574/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609141574/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","BK1515","01877","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667658586","title":"港股異動 | 君實生物(01877)升逾3% 兩款雙特異性抗體新藥均計劃在年內啓動關鍵III期臨床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2667658586","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667658586?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 14:15","pubTimestamp":1789366522,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，君实生物(01877)涨超3%，截至发稿，涨3.07%，报17.11港元，成交额1995.51万港元。消息面上，9月14日，君实生物在2026年半年度业绩说明会上披露核心创新药管线的最新研发进展。公司明确表示，两款备受关注的双特异性抗体新药均计划在2026年内启动关键的III期临床研究。其中，靶向CD20/CD3的双抗药物JS203将正式进入III期临床阶段；而另一款靶向PD-1/VEGF的双抗药物JS207目前正处于II期临床研究阶段，正在多个瘤种中积极开展与化疗、单抗及ADC等不同治疗手段的联合用药探索，并同样预计于2026年内启动III期临床试验。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495540.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KCAI","BK4585","BK1515","BK1161","VXUS","BK1583","BK4588","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667963749","title":"《大行》大華繼顯：手機供應鏈分化  看好「果鏈股」及AI硬件商  維持行業「增持」評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2667963749","media":"阿斯达克财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667963749?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 13:09","pubTimestamp":1789362540,"startTime":"0","endTime":"0","summary":"大华继显发表报告，指本业绩期以苹果及高端敞口的供应商相对更具韧性，低端及中端安卓手机则受元件涨价严重冲击，该行预期压力将持续至2027年，并偏好“果链股”多于安卓供应链，因其出货、利润率及平均售价更具韧性；同时看好业务已切实多元化至AI设备及AI服务器的厂商，认为可提供有意义缓冲。该行维持行业“增持”评级，并看好AI硬件多于手机供应链。)相关内容《大行》大摩：小米SkyNomad新订单强劲  评级“增持”AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220406110137913_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220406110137913_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544293/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544293/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2083900584.USD","LU0238689110.USD","LU2092937148.SGD","AAPY","LU1206712785.SGD","LU0316494557.USD","IE0004445239.USD","IE00B3S45H60.SGD","LU0081259029.USD","LU1823568750.SGD","LU0096364046.USD","LU1506573853.SGD","IE00BJTD4V19.USD","LU2471134796.USD","HK0000532082.HKD","LU0795875169.SGD","LU2381873111.SGD","BK1096","LU2065171311.SGD","BK1582","LU2047632596.USD","LU0786609619.USD","LU0949170426.SGD","LU1066051225.USD","LU2506951958.HKD","LU2505996509.AUD","JGRO","LU1718418525.SGD","LU0417517546.SGD","BK4515","LU0080751232.USD","LU0444971666.USD","LU0353189763.USD","LU1116320737.USD","AAPU","LU2420271590.USD","LU1291159041.SGD","LU0456855351.SGD","LU1551013342.USD","IE00BK4W5L77.USD","LU1119994496.HKD","LU2452424414.USD","LU0061474960.USD","LU0672654240.SGD","SG9999014575.USD","LU0348766576.USD","LU2750360641.GBP","LU0476273544.USD","IE000MB6IJN5.SGD","SG9999006597.SGD","LU1496350171.SGD","LU0109391861.USD","LU1116320901.HKD","BK1607","BK4501","LU0234572021.USD","IE000SO60NU8.SGD","IE00BJJMRY28.SGD","IE00BSNM7G36.USD","LU0957808578.USD","LU0642271901.SGD","LU2271345857.HKD","LU1815336760.USD","SG9999017495.SGD","LU0310800379.SGD","LU1852331112.SGD","LU0640476718.USD","LU2089283258.USD","VT","LU0689472784.USD","IE00BKDWB100.SGD","LU0724617625.USD","LU1934455863.HKD","LU0738911758.USD","LU0310799852.SGD","01415","IE0009356076.USD","LU2054465674.USD","LU1803068979.SGD","LU0820561909.HKD","BK4592","LU2860962120.EUR","SG9999014542.SGD","XLK","IE00BFSS8Q28.SGD","IE00BJTD4N35.SGD","LU2506952097.USD","IE00BZ1G4Q59.USD","LU0308772762.SGD","BK1608","LU0133085943.USD","IE00B19Z8W00.USD","LU1868837300.USD","LU1989772840.SGD","AAPD","LU0211328371.USD","LU0965509010.AUD","LU2471134952.CNY","LU0345770993.USD","LU2462591277.SGD","BK4566","LU2168564222.USD","LU2077746001.SGD","LU1003077747.HKD","LU1206713676.USD","LU1244550577.SGD","LU1935043023.USD","BK4574","LU2028103732.USD","LU0957791311.USD","LU0069063385.USD","LU2750360997.AUD","LU0444973449.USD","LU1267930730.SGD","IE00B19Z9505.USD","LU0882574139.USD","LU0057025933.USD","LU1232071149.USD","LU0326950275.SGD","LU1582986359.USD","LU0210536198.USD","IE000ITXATA3.USD","IE00BMPRXN33.USD","LU0348767384.USD","LU1066051811.HKD","LU0965509101.SGD","LU2552382215.SGD","LU3102509885.SGD","IE000Q6AESB8.SGD","LU2954938101.SGD","HK0000914686.HKD","IE000WAW04H5.SGD","LU0096362180.USD","LU2505996681.GBP","LU2462591350.SGD","LU2242649171.HKD","IE00BLSP4239.USD","LU0323591593.USD","LU0943347566.SGD","ABFL","LU2361044949.HKD","HK0000320264.USD","IE0003U64NQ7.SGD","BK1515","IE00BMPRXQ63.HKD","LU1699723380.USD","LU0528227936.USD","LU0965508806.USD","LU1815333072.USD","LU0158827781.USD","LU0256863811.USD","LU0234570918.USD","LU0162691827.USD","SG9999015952.SGD","BK1521","IE00B031HY20.USD","LU2592432038.USD","IE000YTNTUN2.SGD","IE0009G5SDU7.USD","LU2237443978.SGD","LU1989772923.USD","LU2456880835.USD","LU0143551892.USD","LU0511384066.AUD","LU0348723411.USD","LU0868494708.USD","IOSX","LU2347655156.SGD","BK4598","LU1280957306.USD","IE00BK4W5M84.HKD","LU1989764748.USD","TYLG","LU1037948541.HKD","LU1791710400.SGD","LU0128525929.USD","BK4553","LU0466842654.USD","LU1732799900.SGD","SG9999015986.USD","LU0289961442.SGD","LU0320765489.SGD","SG9999001424.SGD","IE00BN8TJ469.HKD","IE00B775H168.HKD","LU1988902786.USD","HK0000306701.USD","BK4512","LU0354030438.USD","BK4581","LU1571399168.USD","BK4507","IE00BN29S564.USD","LU0949170772.SGD","LU2125154935.USD","IE0008368742.USD","LU1979441026.SGD","LU2213496289.HKD","LU2896262040.SGD","BK4550","BK1167","LU2347655073.USD","LU0154236417.USD","LU0345769631.USD","LU0203201768.USD","LU0079474960.USD","LU1935043536.SGD","CMAG","BK4573","LU0170899867.USD","LU0265550359.USD","SG9999014914.USD","IE00B7KXQ091.USD","LU1066051498.USD","IE000BZT7R73.USD","SG9999002224.SGD","LU0127658192.USD","LU1261432733.SGD","SG9999015978.USD","LU1720051017.SGD","LU0210528500.USD","LU1316542783.SGD","LU0208291251.USD","LU1084165304.USD","LU0314106906.USD","LU0545039389.USD","IE00BFSS7M15.SGD","IE0004086264.USD","IE00BWXC8680.SGD","LU2463028550.USD","BK4559","LU1935042215.USD","LU0314104364.USD","LU1582987597.SGD","LU2023251221.USD","LU0256863902.USD","LU2191332357.HKD","BK4579","LU0011850046.USD","IE0034235303.USD","LU1582987324.SGD","SG9999018857.SGD","LU2361045086.USD","LU2746668461.USD","LU0072462426.USD","LU0823421416.USD","02018","LU0820561818.USD","LU0289739343.SGD","LU2756315318.SGD","BK1149","LU0158827948.USD","LU2237443465.HKD","LU1804176565.USD","BK4533","LU2125154778.USD","LU2065170008.USD","LU2242650005.HKD","LU0274383008.USD","BK4532","02382","FTEC","LU2602419157.SGD","AAPX","LU2237443549.SGD","LU0868494617.USD","LU0251132253.USD","LU2168563687.JPY","LU1551013425.SGD","LU0157215616.USD","LU0661504455.SGD","LU1400636491.USD","LU1145028129.USD","LU0788109477.HKD","LU1366192091.USD","LU1064131342.USD","SG9999015358.SGD","SG9999014898.SGD","LU0823421333.USD","LU2999663052.SGD","LU1935042991.SGD","IE00BYXW3230.USD","LU0787776722.HKD","LU0689626769.HKD","LU2065169927.USD","BK4575","LU1035775433.USD","LU0912757837.SGD","LU2168564149.EUR","SG9999014674.SGD","AAPB","IE000KEQY171.SGD","IE0005OL40V9.USD","LU0267386448.USD","IE0008369823.USD","BK4588","LU2237438978.USD","LU1674673691.USD","LU2360032135.SGD","IE00BJJMRX11.SGD","LU2065171402.SGD","LU2506951875.HKD","LU1144417596.USD","LU0964807845.USD","LU0820562030.AUD","AAPE","LU1244550221.USD","LU1935043452.HKD","LU1267930490.SGD","SG9999000418.SGD","HK0000914660.USD","IE00BDCRKT87.USD","IE0000B7K699.USD","LU1127390331.HKD","BK4554","LU0494093205.USD","GB00BDT5M118.USD","IE00BBT3K403.USD","LU2087625088.SGD","LU1548497426.USD","LU0823417737.USD","BK1504","LU1069344957.HKD","ROM","IE0004445015.USD","LU2471134879.HKD","IE00BJLML261.HKD","HK0000306685.HKD","LU0215105999.USD","LU0345768153.USD","LU0029864427.USD","LU2746668974.SGD","LU1242518857.USD","LU0149725797.USD","LU2430703178.SGD","LU0077335932.USD","LU1235294995.USD","LU1211504680.USD","LU1066053197.SGD","LU2092627202.USD","VGT","LU0109392836.USD","LU1400636574.HKD","LU1202635105.USD","LU2023250504.SGD","LU1645745479.HKD","LU1670756490.USD","IE000W1ABFV2.USD","LU2286300806.USD","IXN","LU2237443382.USD","IE00B19Z8X17.USD","LU1242518931.SGD","LU1914381329.SGD","BK4585","IE00B29SXG58.USD","IE00B1BXHZ80.USD","LU0353189680.USD","SG9999014880.SGD","LU0784385170.HKD","LU2458330243.SGD","LU0174119429.USD","LU1301847155.USD","LU2756315664.SGD","LU1831875114.USD","BK4170","AACAY","BK4576","LU2100268510.USD","LU2430703095.HKD","LU1037948897.HKD","LU2487616109.SGD","LU0557290698.USD","LU0823434583.USD","APLY","LU2236285917.USD","LU2471134523.USD","IE00BQXX3C00.GBP","BK1589","LU2168564065.EUR","LU0950375773.USD","06613","LU0979878070.USD","LU1989771016.USD","LU0354030511.USD","LU2168564495.EUR","LU1720051108.HKD","LU0345770308.USD","LU0942090050.USD","LU2023250330.USD","LU2461242641.AUD","LU0985320562.USD","SGXZ80539844.SGD","LU0056508442.USD","LU2247934214.USD","IE00B4JS1V06.HKD","LU1934455194.USD","LU2250418816.HKD","IE0001KFT4U8.USD","SG9999014567.USD","LU0823417653.USD","IE00B3SWFQ91.USD","METV","IE00B1XK9C88.USD","LU0795875086.SGD","LU1366333091.USD","LU2552382058.USD","LU1074936037.SGD","LU0097036916.USD","BK1170","LU1582986433.USD","IE00BKVL7J92.USD","SG9999002232.USD","LU1400636657.SGD","LU2417539215.USD","BK4505","LU2089284900.SGD","LU2543165471.USD","IE00BQXX3D17.EUR","LU0345769128.USD","LU1868836591.USD","LU0124676726.USD","BK4527","LU1791710582.SGD","LU0708994859.HKD","LU0198837287.USD","LU2430703251.USD","LU1868836757.USD","LU0889565833.HKD","LU1917777945.USD","SPTE","LU1674673428.USD","HK0000819398.USD","BK1179","LU2506952170.USD","LU0784384876.USD","IE00BQXX3F31.USD","IE00BLSP4452.SGD","LU0823434740.USD","LU0070217475.USD","IE0034235295.USD","LU1868836914.USD","TTXU","LU2237443622.USD","BK4534","AAPW","LU2106854487.HKD","LU1934455277.USD","LU0965509283.SGD","00285","LU0210533765.USD","HK0000320223.HKD","LU2097344357.USD","LU0265550946.USD","01478","BK1580","IE00B5949003.HKD","IE00B775SV38.USD","LU1244550494.USD","LU1732800096.USD","LU2087621335.USD","LU0211327993.USD","LU0345768740.USD","300433","BK4571","LU0784383803.USD","LU2360106780.USD","LU0061475181.USD","LU0726765562.USD","SG9999015341.SGD","LU0784385840.USD","LU2462157665.USD","LU1814569148.SGD","LU1642822529.SGD","LU0719512351.SGD","AAPL","IE00BMPRXR70.SGD","LU0320765059.SGD","LU2097344431.USD","BK1500","LU1496350502.SGD","LU2637965513.SGD","LU2237443895.HKD","IE0004091025.USD","MACW.SI","LU2458330169.SGD","SG9999014906.USD","LU1868837136.USD","LU0472753341.HKD","IE000F7OJYX1.SGD","SGXZ31699556.SGD","LU1935042488.USD","LU2265009873.SGD","SG9999014559.SGD","LU2552382132.HKD","LU0053666078.USD","LU1839511570.USD","LU2063271972.USD","LU2111349929.HKD","LU1778281490.HKD","LU2108987350.USD","LU2264538146.SGD","LU2133065610.SGD","LU2403377893.USD","LU2023250843.SGD","LU1267930573.SGD","LU1629891620.HKD","SAAPLmain","IE00B4YYXB79.USD","BK1540","LU0553294199.USD","LU2361044865.SGD","SG9999018865.SGD","LU1046421795.USD","LU1989764664.SGD","SG9999015945.SGD","LU0048584097.USD","LU0082616367.USD","LU0203202063.USD","LU1974910355.USD","LU0072461881.USD","LU2357305700.SGD","LU0070302665.USD","LU0708995401.HKD","LU0861579265.USD","LU0683600562.USD","IE00BDRTCR15.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667632971","title":"《大行》野村：中生製藥(01177.HK)向大股東增購正大天晴5%股權  市場認可交易戰略價值惟對估值存疑","url":"https://stock-news.laohu8.com/highlight/detail?id=2667632971","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667632971?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 11:51","pubTimestamp":1789357860,"startTime":"0","endTime":"0","summary":"野村发表报告指，中生制药将以现金约44.8亿元人民币，向执行董事兼主要股东谢承润增购非上市附属公司正大天晴额外5%股权，交易按正大天晴股权估值896亿元人民币计算，完成后，中生制药持股将由60%升至65%。野村维持对中生制药“买入”评级，目标价8.67元。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190604131528273_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190604131528273_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544269/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544269/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1521","01177","BK1589","IE00BZ08YT58.USD","BK1574","01477","BK1515","HK0000165453.HKD","BK1191","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667310766","title":"《股市簡訊》復星醫藥H股升2.5%，地舒單抗生物類似藥HLX14的註冊申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2667310766","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667310766?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 10:30","pubTimestamp":1789353058,"startTime":"0","endTime":"0","summary":"《股市简讯》复星医药H股升2.5%，地舒单抗生物类似药HLX14的注册申请获受理* 中国复星医药H股2196.HK周一早盘一度升2.5%，其A股600196.SS涨1.5%，地舒单抗生物类似药HLX14的注册申请获受理。* 该公司此前公告称，控股子公司--上海复宏汉霖及其控股子公司自主研发的地舒单抗生物类似药HLX14 120mg/瓶规格的药品注册申请获国家药品监督管理局受理。* 复星医药H股今年迄今大跌14.4%，同期A股挫近两成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4T45604K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK0187","BK0028","BK0196","BK0188","BK1515","BK1593","BK0096","BK0175","BK0239","BK0012","BK0060","02196","BK0183","600196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667083631","title":"醫藥板塊表現強勢 凱萊英（06821）升逾5% 機構制AI製藥商業化風口初步顯現","url":"https://stock-news.laohu8.com/highlight/detail?id=2667083631","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667083631?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 10:26","pubTimestamp":1789352818,"startTime":"0","endTime":"0","summary":"消息面上，招商证券指出，自2024年以来，AI制药发展速度明显加快，投资规模和项目数量显著增长。跨国药企开始大规模搭建自有AI平台能力，合作模式由单点项目合作转向管线与平台层面深度合作。AI科技巨头入局药物研发领域，依托通用大模型推出面向药物研发的专用AI模型。AI Biotech的合作机会与交易规模持续扩容，即便尚未拥有成熟商业化管线，也获得传统药企青睐。AI制药行业已完成概念验证，正式迈入临床验证阶段，商业化风口初步显现。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/YjA5ZTU5M2U3ZjIyNGI4Mzk2MWM1NGUyNWZkZjFmMjE3MzEwNTIzMzcxNTY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjA5ZTU5M2U3ZjIyNGI4Mzk2MWM1NGUyNWZkZjFmMjE3MzEwNTIzMzcxNTY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991473","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","03759","LU0043850808.USD","BK1141","CHAT","KURE","LU1242518931.SGD","LU0417516902.SGD","LU2125910500.SGD","02269","AIPO","VTHR","09939","LU0516422366.SGD","LU1880383366.USD","IE00B0JY6N72.USD","BK1191","01477","BK1583","LU1720050803.USD","QTOC","LU0516422440.USD","LU0516423174.USD","LU1688375341.USD","LU0128526141.USD","LU0819121731.USD","LU0588546209.SGD","02359","002821","SG9999002463.SGD","06821","ARTY","LU1046422090.SGD","AGIX","LU0326950275.SGD","159938","LU0979878070.USD","SG9999002562.SGD","LU2242644610.SGD","LU0348766576.USD","LU0823426480.USD","LU0359201612.USD","LU0417516738.SGD","LU1242518857.USD","BK1515","03347","LU0052750758.USD","BK0239","LU0307460666.USD","BK1610"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667363120","title":"港股異動 | 中國生物製藥(01177.HK)升逾3% 擬44.8億元向謝承潤收購正大天晴5%股權","url":"https://stock-news.laohu8.com/highlight/detail?id=2667363120","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667363120?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 10:19","pubTimestamp":1789352346,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BZ08YT58.USD","HK0000165453.HKD","BK1521","BK1589","IE00BZ08YS42.EUR","01177","BK1191","IE00BZ08YR35.GBP","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667639327","title":"港股公告掘金 | 中國生物製藥擬44.8億元向謝承潤收購正大天晴5%股權 完成後間接持股增至65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667639327","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667639327?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 09:01","pubTimestamp":1789347690,"startTime":"0","endTime":"0","summary":"重大事项：中国生物制药(01177)拟44.8亿元向谢承润收购正大天晴5%股权 完成后间接持股增至65%俊知集团(01300)：拟4.55亿元收购青海中利光纤技术100%股权中国宏桥(01378)附属拟2.4亿元收购魏桥新创全部股权阜博集团(03738)旗下附属公司与蚂蚁数科订立合作协议 携手共建版权大模型中国派对文化(01532)拟出售浙江云游智慧文旅集团注册资本总额的32%德适-B(02526","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495434.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01177","BK1149","KCAI","BK1585","BK1100","HK0000165453.HKD","BK1589","BK1506","BK4585","VXUS","01300","BK1148","BK4588","BK1555","02526","IE00BZ08YR35.GBP","03728","IE00BZ08YT58.USD","BK1191","BK1521","BK1515","01030","BK1240","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667364266","title":"【灣區早參】澳門第二季本地產品出口總值按季上升6.8%；廣州金融業總資產首次突破14萬億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667364266","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667364266?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 08:42","pubTimestamp":1789346561,"startTime":"0","endTime":"0","summary":"按出口目的地分析，2026年第二季本地产品出口，输往中国内地及美国的货值按季分别上升0.4%及68.0%；输往香港特区及欧洲联盟的则分别下跌1.0%及30.5%。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991451","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0594300179.USD","LU0650527681.SGD","IE00BVYPNP33.GBP","03121","BK1515","IE00BZ08YR35.GBP","BK1538","LU0737861772.HKD","LU0329678170.USD","IE00BZ08YS42.EUR","BK1171","LU0173614495.USD","BK1589","01333","BK1191","02513","LU0315179316.USD","LU0205439572.USD","HK0000165453.HKD","LU0329678337.USD","LU0605514214.HKD","SG9999010052.SGD","IE00BZ08YT58.USD","BK1240","BK1521","BK1175","LU0287142896.SGD","BK1592","LU0593848301.USD","BK1117","BK1555","SG9999010078.USD","IE00BVYPNQ40.USD","IE00BGHQDM52.EUR","LU0594300419.USD","LU1206782309.USD","BK1594","00688","SG9999009997.SGD","BK1178","LU0737861699.HKD","01898","01177","LU1224709979.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667636378","title":"國家醫保局修訂印發2026版醫保服務協議範本","url":"https://stock-news.laohu8.com/highlight/detail?id=2667636378","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667636378?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 08:11","pubTimestamp":1789344663,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1161","BK1574","BK1515","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635664","title":"智通港股早知道 | 沙特輸油管道中斷 全球石油供應恐損失4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635664","media":"智通财经","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635664?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 07:13","pubTimestamp":1789341220,"startTime":"0","endTime":"0","summary":"热门中概股多数上涨，纳斯达克中国金龙指数涨0.40%。沙特输油管道中断 全球石油供应恐损失4%交易商及消息人士称，沙特输油管道中断，若数日内不能恢复输送，全球石油供应恐将损失4%。根据公告，智谱股份配售价为每股714港元，较公告前收盘价折让约9.96%，配售股份占扩大后已发行股本约4.50%。无人配送网络持续扩张，截至2026年上半年，公司无人车网络已覆盖全国124个城市，运营车辆规模超过1000台，月均活跃行程数超6万趟。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495391.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01177","USOI","DRIP","BK4585","BK1521","XLE","09699","OIH","DBC","DBE","IEO","ERX","PXE","BK1191","BK4570","XES","USL","IE00BZ08YT58.USD","VXUS","FTXN","BNO","IE00BZ08YS42.EUR","OILU","IE00BZ08YR35.GBP","IXC","OILK","OILT","USE","HK0000165453.HKD","DIG","WTIU","BK1151","DRLL","XOP","BK1515","VDE","KCAI","PXJ","GUSH","BK1589","BK4588","159019"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667852816","title":"20%漲停效應顯現？公募調研醫藥挖出這三家雙創標的","url":"https://stock-news.laohu8.com/highlight/detail?id=2667852816","media":"证券市场周刊","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667852816?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 11:11","pubTimestamp":1789269060,"startTime":"0","endTime":"0","summary":"Wind资讯显示，从6月以来公募医药基金经理的调研看，比如义翘神州、赛科希德、兴齐眼药等等。Wind资讯显示，本次调研总共有20家机构参与，其中包括了10家券商、5家私募、3家投资机构和2家公募。公司产品不直接用于临床治疗，主要是作为工具试剂，用于支持科研机构和生物医药企业的研究工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2026-09-13/doc-inirrxsh4698780.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","09939","BK1574","159938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667683005","title":"河北一醫院工作人員先後收受商業賄賂46次，單次最大涉案金額1658萬元，持續時間最長達11年，累計涉案金額1.84億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667683005","media":"大象新闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667683005?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 09:18","pubTimestamp":1789262280,"startTime":"0","endTime":"0","summary":"继上海某科贸商行涉支架球囊行贿案公开曝光河北医科大学第二医院“每条支架收5000元回扣”后，仅2025年下半年，该院又涉及9件司法刑事判决。该医院工作人员先后收受商业贿赂46次，单次最大涉案金额1658万元，持续时间最长达11年，累计涉案金额1.84亿元。分析发现，超过30家医药企业长期对该医院工作人员行贿。河北祥恩医疗器械贸易有限公司为向河北医科大学第二医院销售价格虚高的医疗耗材，累计向该医院工作人员行贿2064万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-13/doc-inirrtkk4766738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MDEV","09996","09939","AGNG","BK1515","BK1574","PTH","RSPH","BK1161","GDOC","BK1583","BK1100","MEDX","LGHT","LNGR","IEIH","HART"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":2,"totalSize":205,"code":"91000000","status":"200"}]}}